>

Riociguat from Zhejiang Hengkang

Zhejiang Hengkang Pharmaceutical is an emerging and fast-developing company, which was established in 2004. Hengkang is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketingļ¼Œand it provides the most innovative intermediates and APIs to world-wide customers. Hengkang has 2 manufacturing plants: one is located in Fengkeng industrial zone with a total area of 69000 m2; the other one is located in coastal industrial zone with a total area of 70000 m2. The company has international standard facilities for API manufacturing and a professional team with cutting-edge technology, and provides the most innovative intermediates and active pharmaceutical ingredients. The factories are approved by several authorities, such like Chinese NMPA, US FDA, EU EMA, Japan PMDA and Korea MFDS. For some other authorities we are also in proceeding for approval, such like...

Read full company description
Address: No. 11 Chengen Road, Pubagang Town, Sanmen County, , Taizhou
China
China Local time:

Visit website

has international standard facilities for API

specialized in active pharmaceutical ingredients development and GMP manufacturing

has 3 manufacturing plants

Our clients:

more than 70 countries

Our services:

API
intermediate
CMO/CDMO service
FDF supplying
Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Currently Rephine has no report for this supplier. Contact them to let them know you're interested!

Response time:

All our products

Contact Us

Producer

Produced in:

China

MOQ: -

  • CoA

  • WC

  • MSDS

  • BSE/TSE

  • USDMF

Contact supplier

Replies quickly

Zhejiang Hengkang Riociguat API Producer - 625115-55-1

Description:
Zhejiang Hengkang offers high-quality Riociguat API, certified for compliance with international standards. Manufactured in China. has international standard facilities for API. specialized in active pharmaceutical ingredients development and GMP manufacturing. has 3 manufacturing plants.

Product Details

Certifications
CoA, WC, MSDS, BSE/TSE, USDMF compliant
Minimum Order Quantity
Produced in
China (Asia)
DrugBank ID
DB08931
CAS Number
625115-55-1
Unique Ingredient Identifier
RU3FE2Y4XI
Raw Material Category
sGC stimulator

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 30 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Riociguat API? Contact Zhejiang Hengkang by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Riociguat API

Zhejiang Hengkang

Zhejiang Hengkang Pharmaceutical is an emerging and fast-developing company, which was established in 2004. Hengkang is specialized in active pharmaceutical ingredients development, GMP manufacturing and marketingļ¼Œand it provides the most innovative intermediates and APIs to world-wide customers. Hengkang has 2 manufacturing plants: one is located in Fengkeng industrial zone with a total area of 69000 m2; the other one is located in coastal industrial zone with a total area of 70000 m2. The company has international standard facilities for API manufacturing and a professional team with cutting-edge technology, and provides the most innovative intermediates and active pharmaceutical ingredients. The factories are approved by several authorities, such like Chinese NMPA, US FDA, EU EMA, Japan PMDA and Korea MFDS. For some other authorities we are also in proceeding for approval, such like Brazil ANVISA, etc.